At Pioneera Biosciences, we are excited to announce our latest groundbreaking project focused on the development of Chimeric Antigen Receptor T-cell (CAR-T) and Natural Killer cell (CAR-NK) therapies. These cutting-edge therapies represent a paradigm shift in cancer treatment, harnessing the power of the immune system to target and eliminate cancer cells with unprecedented precision.